FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.1  |  FHIR Version n/a  User: [n/a]

4200711000001102: Lanvis 40mg tablets (GlaxoSmithKline) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18140501000001119 Lanvis 40mg tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
69182101000001114 Lanvis 40mg tablets (Aspen Pharma Trading Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lanvis 40mg tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) Is a Product containing precisely tioguanine 40 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) Has excipient Lactose false Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) Has active ingredient Tioguanine false Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) Is a Lanvis true Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) Has specific active ingredient Tioguanine true Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Lanvis 40mg tablets (GlaxoSmithKline) 25 tablet Is pack of False Lanvis 40mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Lanvis 40mg tablets (GlaxoSmithKline) 25 tablet Has AMP True Lanvis 40mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start